FDA clears Motilent's AI gastrointestinal imaging software

By AuntMinnie.com staff writers

November 24, 2021 -- The U.S. Food and Drug Administration (FDA) has cleared Motilent's artificial intelligence (AI)-based gastrointestinal imaging software.

The company plans to roll out the software, called GIQuant, in partnership with Nuance Communications. It is used with MRI exams to measure and track the movement of the intestine; measuring this movement can help clinicians diagnose gastrointestinal conditions such as Crohn's disease.


Copyright © 2021 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: